Abstract:Objective·To study the clinical features of two primary Sjögren's syndrome (pSS) patients with neurological symptoms as initial manifestations and review the related literature.Methods·The clinical data, response to treatment as well as prognosis of 2 cases were analyzed and followed up.Results·Case 1, female, initially presented progressive gait instability and distal sensory impairment at the age of 50. Clinical manifestations included spastic gait, sensory ataxia, conduction fascicular sensory impairment, as well as urination and defecation dysfunction. At the age of 58, this patient was unable to walk independently. The laboratory findings revealed a positive result for anti-nuclear antibody with a titer of 1∶1 000, anti-Sjögren's syndrome A (SSA)/Ro-52, anti-SSA/Ro-60, and anti-centromere antibodies. Labial salivary gland biopsy showed lymphocytes and plasma cells infiltration into the glandular tissues, interstitium, and lobules, with 2 foci/4 mm2 (lymphocytes >50). The cranial magnetic resonance imaging exhibited bilateral symmetric hyperintensity in the brainstem, characterized by the "snake-eye sign". Electromyography examination revealed axonal impairment of the right peroneal nerve. The patient was treated with high-dose corticosteroid therapy in combination with immunosuppressants. She experienced remarkable improvement. After three months, she was able to walk with aids and take care of herself in daily life. Case 2, female, presented spasmodic torticollis since the age of 81 with unknown reason. She had a history of mild mucosal dryness of mouth and eyes, and painful knee for one year. Laboratory findings revealed positive results for anti-SSA/Ro-52 and anti-SSA/Ro-60 antibodies, as well as hemoglobin of 86 g/L. Labial salivary gland biopsy demonstrated partial atrophy of the acini and the presence of 2 foci/4 mm2 of lymphocytes and plasma cells infiltration into the stroma (lymphocytes>50). Electromyography examination showed reduced conduction velocity in the right median nerve. She got a significant relief after the treatment of immunosuppressants, antispasmodics, and muscle relaxants.Conclusion·Patients presenting initial symptoms such as complex forms of spastic paraplegia and cervical dystonia expand the clinical spectrum of pSS. In clinical practice, it is important to distinguish neurological involvement secondary to pSS from other primary neurological disorders. For patients with neurological impairments but without apparent etiology, it is crucial to screen relevant series of autoimmune antibodies.

Trigeminal neuropathy as a complication of systemic sclerosis: case reports and literature review

Clinical analysis of 9 cases of connective tissue diseases with trigeminal neuropathy

Evaluation of visceral involvement and detection of autoantibodies in patients with systemic sclerosis

[Clinico-Electrophysiological and Pathological Characteristics of Neuropathy in Sjögren's Syndrome: a Report of 5 Cases].

Somatosensory and Trigeminal Pathway Abnormalities in Chinese Patients with Trigeminal Neuralgia.

Neurosarcoidosis of the trigeminal nerve: clinical accompaniments, radiographic findings, and association with neuralgia

Hypophysitis and central nervous system involvement in association with Sjögren's syndrome along with hypoparathyroidism: a case report

Further insight into systemic sclerosis from the vasculopathy perspective

Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers

Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography

Ocular Involvement in Systemic Sclerosis: Updated Review and New Insights on Microvascular Impairment

Two Cases of Primary Sjögren's Syndrome with Neurological Impairment As Initial Symptom

Epidemiology and Treatment of Peripheral Neuropathy in Systemic Sclerosis

Spontaneous tendon rupture in a patient with systemic sclerosis: a case report

Trigeminal neuralgia as the sole neurological manifestation of COVID‐19: A case report

The clinical features of neuromyelitis optica spectrum disorders with Sjogren's syndrome

Symptomatic trigeminal autonomic cephalalgias in neuromyelitis optica spectrum disorders

Trigeminal neuralgia in multiple sclerosis: Prevalence and association with demyelination

Trigeminal neuropathy presenting secondary to SARS-CoV-2 infection

Retinal Vascular Abnormalities and Clinical Parameters in Systemic Sclerosis